GLP-1 Weight Loss Options
US$ 24.73
evaluate the pharmaceuticals company saxenda on amgen and glp-1 Roche was among first pharmaceutical companies to research drugs in the glucagon-like peptide-1 (GLP-1) class but abandoned the field after late-stage flops just before the latest boom began. Having Visible Alpha GLP-1 drug monitor
Description
Youd struggle to find pharma BD teams discussing their interest in acquiring assets in the space
Reid A et al
Over 50% of patients stop GLP-1s within a year (AJMC), often due to side effects or lack of guidance
The mean duration of type 2 diabetes mellitus was 15 years and the mean BMI was 31 kg/m2
Enhanced bile acid synthesis: By increasing cholesterol conversion to bile acids, glucagon may reduce cholesterol stores and circulating LDL
